Source abstract
Abstract
Implantation of biomedical devices is often followed by bacterial infections that may seriously affect implant functionalities and lead to their failure. In the context of bacterial resistance to antibiotics, which is a growing problem worldwide, new strategies that are able to overcome these problems are needed. In this work, we introduce a new formulation of hyaluronic acid (HA)-based antimicrobial material: HA hydrogels loaded with polyarginine (PAR), a polycationic antibiotic substitute. The loading is possible through electrostatic interactions between negatively charged HA and positively charged PAR. Such hydrogels absorb high quantities of PAR, which are then gradually released from the hydrogel. This original system provides a long-lasting antibacterial effect on an in vitro model of repetitive infection, thus demonstrating a strong potential to fight multiple rounds of infections that are resistant to antibiotic treatment. In addition, HA-PAR hydrogels could be deposited onto/into medical devices such as wound dressings and mesh prostheses used in clinical applications. Finally, we performed first in vivo tests of hydrogel-coated mesh materials to verify their biocompatibility in a rat model, which show no difference between control HA hydrogel and PAR-loaded hydrogel in terms of inflammation.
Source: openalex_inverted_index · Quality: baseline
Affiliations
Institut National de la Santé et de la Recherche Médicale, INSERM Unité 1121 Biomaterials and Bioengineering, 11 rue Humann, 67085 Strasbourg Cedex, France
Faculté de Chirurgie Dentaire, Université de Strasbourg, 8 rue Sainte Elisabeth, 67000 Strasbourg, France
Institut Charles Sadron, CNRS UPR 22, 23 rue du Lœss, 67034 Strasbourg, France
Institut Claudius Regaud, Institut Universitaire de Toulouse Oncopole, 1 Avenue Irène Joliot Curie, 31059 Toulouse Cedex 9, France
SPARTHA Medical, 11 rue Humann, 67000 Strasbourg, France
Funding
European Regional Development Fund · H2020 European Research Council